Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in Acute Coronary Syndromes
NCT07064109Recruiting
- Sponsor
- Tongji Hospital
- Start
- Jul 2025
- Primary completion
- Jul 2027
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Open-label trial of colchicine in acute coronary syndrome (ACS) (2 arms), sponsored by Tongji Hospital. Primary endpoints: Number of responder at 6 months and Number of Participants with Advances in Coronary Artery Physiology and Function at 1 year. Started Jul 2025; status: recruiting.
02
Drugs
colchicine
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT07064109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07064109.